Where does Sofradim Production rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sofradim Production ranks #2,567 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sofradim Production hold?

Sofradim Production holds 152 US utility patents granted between 2015 and 2025, spanning 46 technology areas.

What is Sofradim Production's Innovation Score?

Sofradim Production has an Innovation Score of 58.4 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sofradim Production's patent grant rate increasing or decreasing?

Sofradim Production's recent grant velocity is -23% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sofradim Production's patents?

Sofradim Production's patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sofradim Production patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sofradim Production

Q: What technology areas does Sofradim Production focus on?

Sofradim Production's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 105 patents, ranking #47 of 3,082 assignees active in that subclass. Grants appear in 46 CPC subclasses total.

USPTO PatentsView assignee record - 152 granted patents across 46 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sofradim ranks #2,567 of 49,997 tracked US assignees by granted-patent volume, with 152 patents across 46 technology areas.

#2,567
of 49,997 US assignees by volume: Top 5%
by Innovation Score (58.4/100): 18.6
avg claims per patent: -23%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2567 · Foreign Corporation #2,567 · 152 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 152 grants
TOP-DECILE #2,567/49,997
PHOTO-FINISH Merlin Technology
CPC-WIDE A61F · 46 areas
INNOV-PAR 58.4/100
CLAIMS-RICH 18.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -23% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Merlin Technology Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sofradim’s 58.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.4 pts (30%) Velocity 5.9 pts (10%) Breadth 24.0 pts (41%) Claim depth 11.1 pts (19%)

Qualcomm Incorporated · highest

85
Technische UNIVERSIT… · near

58
The University of… · near

58
ABB E-Mobility B V · near

58
Sofradim Production · this assignee

58
Webasto SE · near

58
3D Lighting… · lowest

7

What this shows Sofradim's Innovation Score is 58.4/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sofradim?

Each dot is one of Sofradim’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sofradim’s own 18.6 claims/patent is ABOVE the 10.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sofradim vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sofradim's grants concentrate

Sofradim Production is a focused PatentsView assignee: 46 CPC subclasses with 69.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (21 grants) versus a trough of 8 in 2021. By volume, Sofradim sits between Merlin Technology Inc. and Amada Co., Ltd..

Sofradim's three-year grant acceleration

From 2019–2021 to 2022–2024, Sofradim Production moved from 42 to 37 grants (0.88x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,550. See the growth leaderboard.

Merlin Technology

152
Nanotek Instrumen…

152
Nevro

152
Peregrine Semicon…

152
Sennheiser & KG

152
The Urban Electric

152
Sofradim Producti… ◀

152
AIR Cool Industri…

151
Amada

151

What this shows Sofradim holds 152 patents at rank #2,566, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sofradim

By rank, the assignees closest to #2,566 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Sofradim's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sofradim, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Sofradim ranks #47 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

Webasto SE 58 ABB E-Mobility B.V. 58 Technische UNIVERSITÄT MÜNCHEN 58 The University of Miami 58

Similar claim depth

Nearest assignees by average claims per patent (18.6 here).

Adesto Technologies Corporation 18.6 avg Applied Research Associates, Inc. 18.6 avg Rackspace US, Inc. 18.6 avg Ocient Holdings LLC 18.6 avg

Sofradim's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sofradim Production patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	13	8.6%
2016	21	13.8%
2017	14	9.2%
2018	18	11.8%
2019	16	10.5%
2020	18	11.8%
2021	8	5.3%
2022	12	7.9%
2023	12	7.9%
2024	13	8.6%
2025partial year	7	4.6%

Which technologies does Sofradim Production patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 105

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 60

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 49

D04B - Knitting 48

A61B - DIAGNOSIS; SURGERY; Identification 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

Y10T - Technical Subjects Covered BY Former US Classification 12

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 9

C08L - Compositions OF Macromolecular Compounds 8

D06C - Finishing, Dressing, Tentering OR Stretching Textile Fabrics 7

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 7

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 6

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 6

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 5

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 5

Top 15 of 46 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sofradim Production's patent record in context - here's where to go next.

Sofradim Production's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 69.1% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #2,567 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sofradim Production against Merlin Technology Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 58.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.